March 2024 Newsletter
Welcome to the March Cresset newsletter where we share our latest results for GPCR benchmarks using Flare™ FEP, Cresset wins ...
News
Flare™ V5 is now available. This release of our comprehensive platform for drug design features new and enhanced science, integration of ligand and protein-based approaches and new and improved GUI features to increase usability.
Thank you to everyone who attended our User Group Meeting, which was held again virtually this year. If you were unable to attend, or if you'd like to hear about the latest developments from Cresset scientists and software users, the presentations are available upon request.
Virtual screening is a powerful computational technique for exploring new chemical space and generating new IP in the search for novel hits. Whether you have a dedicated internal team and resources, or you are new to virtual screening, Cresset can work with you to devise the best approach for your project.
We explore some of the key functionalities within Torx Make™ that simplify the setup and delivery of synthesis targets by CRO teams through secure sharing, communication and in-application reporting.
Martin Slater, Director of Consulting Services, explains the diverse range of organizations that outsource computational chemistry and the cross-industry expertise his team can offer.
July 13th Increase productivity in your synthesis projects with real-time progress tracking |
July 13th and 14th New features and enhancements |
July 15th How quantum technology can accelerate the drug discovery process |
Torx Make enables synthetic chemistry teams to capture and manage all project compounds and contextual information in a single location, allowing users to share progress in real-time without laborious reporting. In this webinar, we'll show you how easy it is to learn the status of every project compound and design in seconds. |
We will introduce the new features available when designing and running FEP simulations in Flare V5 which make the user experience easier and the calculations faster, allowing more molecules to be incorporated into a single drug discovery project. |
Hear from Novartis, Cresset and Fujitsu as they discuss the impact of technological advances in quantum computing and how they’ve applied quantum-inspired innovations themselves to deliver speed, efficiency and cost benefits within their organisations. |